CeNeRx BioPharma Announces $18.5 Million Series A Financing

News | 11. 29. 2005

CeNeRx BioPharma

CeNeRx BioPharma, Inc., a start up bio-pharmaceutical company focused on developing new therapeutics for disorders of the central nervous system, today announced the completion of $18.5 million in series A financing.